<?xml version="1.0" encoding="UTF-8"?>
<p>Breast cancer (BC) is one of the most common malignant tumors and a major cause of cancer death among women worldwide, and the triple-negative breast cancer (TNBC) subtype is the most aggressive one [
 <xref rid="B1" ref-type="bibr">1</xref>]. Worldwide statistics showed that in 2018, approximately two million new cases were detected, with the total BC cases accounting for 11.6% of all cancers. Therefore, the search for effective anticancer agents is urgent for BC therapy and to improve the quality of life of patients.
</p>
